Tuteja Sony, Wang Lu, Dunbar Richard L, Chen Jinbo, DerOhannessian Stephanie, Marcovina Santica M, Elam Marshall, Lader Ellis, Rader Daniel J Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy. , Pharmacogenetics and genomics, 27(8): 2017,285-293

Empey Philip E, Stevenson James M, Tuteja Sony, Weitzel Kristin W, Angiolillo Dominick J, Beitelshees Amber L, Coons James C, Duarte Julio D, Franchi Francesco, Jeng Linda J B, Johnson Julie A, Kreutz Rolf P, Limdi Nita A, Maloney Kristin A, Owusu Obeng Aniwaa, Peterson Josh F, Petry Natasha, Pratt Victoria M, Rollini Fabiana, Scott Stuart A, Skaar Todd C, Vesely Mark R, Stouffer George A, Wilke Russell A, Cavallari Larisa H, Lee Craig R Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy. , Clinical pharmacology and therapeutics, 104(4): 2018,664-674

Cavallari LH, Beitelshees AL, Blake KV, Dressler LG, Duarte JD, Elsey A, Eichmeyer JN, Empey PE, Franciosi JP, Hicks JK, Holmes AM, Jeng L, Lee CR, Lima JJ, Limdi NA, Modlin J, Obeng AO, Petry N, Pratt VM, Skaar TC, Tuteja S, Voora D, Wagner M, Weitzel KW, Wilke RA, Peterson JF, Johnson JA The implementing genomics in practice (IGNITE) pharmacogenetics interest group: An opportunity for building evidence with pharmacogenetics implementation. , Clinical and Translational Science , 10(3): 2017,143-143

Dunbar RL, Goel H, Tuteja S, Brent C, Babbar Z, Lalic D, Gelfand JM, Rader DJ, Grove GL Measuring physical properties of erythema by laser Doppler flowmetry, white-light spectroscopy, colorimetry, thermometry, and eicosanoid Biomarkers. , Journal of Lipid Research , 58(4): 2017,783-797

Quatromoni N, Tuteja S, Kolansky DM, Matthai WH and Giri J Novel anti-platelet agents in acute coronary syndrome: mechanisms of action and opportunities to tailor therapy. , Curr Atheroscler Rep, 7(5): 2015,501

Tuteja S, Rader DJ High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm. , Clinical Pharmacology and Therapeutics , 96(1): 2014,48-56

Tuteja S and Rader DJ Dyslipidaemia: cardiovascular prevention—end of the road for niacin? , Nature Reviews Endocrinology, 10(11): 2014,646-647

Tuteja S, Duffy D, Dunbar RL, Movva R, Gadi R, Bloedon LT, Cuchel M Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia. , Pharmacotherapy, 34(3): 2014,227-239

Tuteja S, Haynes K, Zayac C, Sprague JE, Bernhardt B, Pyeritz R Community pharmacists' attitudes towards pharmacogenetic testing. , Personalized Medicine, 10(8): 2013,793-800